Skip to main content
. 2022 Oct 25;16:3723–3735. doi: 10.2147/DDDT.S381546

Figure 2.

Figure 2

Semaglutide significantly reduced fasting glucose, lipid and inflammatory indexes. The levels of TG, CHO, LDL, HDL, TNF-α, IL-6, IL-1β and HOMA-IR in different groups were detected. **P < 0.01 or ***P < 0.001 indicated vs NC group; #P < 0.05 or ##P < 0.01 indicated vs HFD group.